NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Pemirolast

Last Revision: December 3, 2018.

CASRN: 69372-19-6

Chemical structure

Drug Levels and Effects

Summary of Use during Lactation

Although no published data exist on the use of pemirolast during lactation, maternal milk levels are likely to be very low after the use eye drops.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Pemirolast

CAS Registry Number

69372-19-6

Drug Class

  • Breast Feeding
  • Lactation
  • Anti-Allergic Agents
  • Histamine Antagonists

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK501685PMID: 30000745